Choriocarcinoma as a cause of thyrotoxicosis.
Three patients with choriocarcinoma had clinical and biochemical evidence of hyperthyroidism. Diminution in the thyrotoxicosis closely paralleled the fall in human chorionic gonadotrophin (hCG) levels. Three patients originally presented to internal medicine units as a problem of hemoptysis. Thyroid-stimulating hormone bioassay activity was demonstrated in the serum of all three patients prior to therapy. Recently evidence has been presented that hCG has intrinsic thyrotropic activity and that in conditions, such as hydatidiform mole, in which serum hCG levels are grossly elevated this thyrotropic activity can be sufficient to produce hyperthyroidism. Two of our cases supported the concept that hCG was also the substance with thyroid-stimulating activity in patients with choriocarcinoma. The third case left open the possibility that, in addition to the thyroid-stimulating activity of hCG, there may also be the production of a true ectopic thyroid-stimulating hormone (TSH). It is considered that the development of biochemical and clinical thyrotoxicosis in patients with choriocarcinoma depends upon the duration of the choriocarcinoma and the level of hCG.
D000328:Adult; D002822:Choriocarcinoma / Q000150:complications*; D006063:Chorionic Gonadotropin / Q000097:blood / Q000652:urine; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000209:etiology*; D011247:Pregnancy; D013960:Thyroid Function Tests; D013972:Thyrotropin / Q000097:blood
D006063:Chorionic Gonadotropin; D013972:Thyrotropin